Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data

BACKGROUND: Patients with end-stage renal disease (ESRD) require phosphate binders for hyperphosphatemia and erythropoiesis-stimulating agents (ESAs) and intravenous (IV) iron for anemia. Ferric citrate (FC) is a novel, iron-based phosphate binder that increases iron stores and decreases IV iron and...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodby, Roger A., Umanath, Kausik, Niecestro, Robert, Christopher Bond, T., Sika, Mohammed, Lewis, Julia, Dwyer, Jamie P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561055/
https://www.ncbi.nlm.nih.gov/pubmed/26239948
http://dx.doi.org/10.1007/s40268-015-0103-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561055/
https://www.ncbi.nlm.nih.gov/pubmed/26239948
http://dx.doi.org/10.1007/s40268-015-0103-y

Ejemplares similares